Bank of New York Mellon Corp - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,585,106
-34.2%
58,786
+4.0%
0.00%
-33.3%
Q2 2023$13,051,038
+23.1%
56,498
+29.1%
0.00%
+50.0%
Q1 2023$10,601,781
-15.0%
43,762
+1.8%
0.00%
-33.3%
Q4 2022$12,472,333
+371.5%
42,971
+5.6%
0.00%
+200.0%
Q3 2022$2,645,000
+1.2%
40,702
+11.5%
0.00%0.0%
Q2 2022$2,613,000
-26.3%
36,494
+1.0%
0.00%0.0%
Q1 2022$3,545,000
+20.4%
36,127
+4.0%
0.00%0.0%
Q4 2021$2,945,000
-17.4%
34,744
-22.3%
0.00%0.0%
Q3 2021$3,566,000
-8.0%
44,697
+12.3%
0.00%0.0%
Q2 2021$3,878,000
-4.8%
39,810
+14.3%
0.00%0.0%
Q1 2021$4,074,000
+3.2%
34,827
-1.9%
0.00%0.0%
Q4 2020$3,947,000
-8.2%
35,506
-2.0%
0.00%0.0%
Q3 2020$4,301,000
+2.5%
36,220
-2.2%
0.00%0.0%
Q2 2020$4,195,000
+75.2%
37,046
+3.3%
0.00%0.0%
Q1 2020$2,394,000
-23.1%
35,863
+4.9%
0.00%0.0%
Q4 2019$3,113,000
+11.1%
34,174
+5.2%
0.00%0.0%
Q3 2019$2,802,000
-16.8%
32,495
+1.1%
0.00%0.0%
Q2 2019$3,368,000
-12.7%
32,137
+4.4%
0.00%0.0%
Q1 2019$3,856,000
+11.0%
30,782
-0.1%
0.00%0.0%
Q4 2018$3,473,000
-56.7%
30,815
-17.8%
0.00%
-50.0%
Q3 2018$8,026,000
-16.9%
37,485
+8.5%
0.00%
-33.3%
Q2 2018$9,659,000
+165.6%
34,535
+10.9%
0.00%
+200.0%
Q1 2018$3,637,000
+28.3%
31,148
+0.9%
0.00%0.0%
Q4 2017$2,834,000
+386.9%
30,878
+138.5%
0.00%
Q3 2017$582,000
+225.1%
12,945
+17.9%
0.00%
Q2 2017$179,00010,9820.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders